Amphetamine Completed Phase 2 Trials for Strokes Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02514044Dextroamphetamine and tDCS to Improve the Fluency